Proteomic signatures of corona and herpes viral antibodies identify IGDCC4 as a mediator of neurodegeneration

Mechanisms underlying the dynamic relationships of viral infections and neurodegeneration warrant examination. Using a community-based cohort of older adults, the current study characterized the neurocognitive (cognitive functioning, brain volumes, Alzheimer's disease positron emission tomography, and plasma biomarkers) and plasma proteomic (7268 proteins) profiles of four common coronavirus and six herpesvirus antibody titers. Genetic inference techniques demonstrated the associations between viral antibody titers and neurocognitive outcomes may be attributed to altered expression in a subset of mechanistically relevant proteins in plasma. One of these proteins, IGDCC4 (immunoglobulin superfamily deleted in colorectal cancer subclass member 4), was related to 20-year dementia risk, cognitive functioning, and amyloid-β positivity using data from two independent cohorts, while its plasma and intrathecal abundance were causally implicated in dementia risk and clinically relevant brain atrophy. Our findings illuminate the biological basis by which host immune responses to viruses may affect neurocognitive outcomes in older adults and identify IGDCC4 as an important molecular mediator of neurodegeneration.

Authors

Institutions

Publication Details

Journal
Science Advances
Published
2025-05-30
DOI
https://doi.org/10.1126/sciadv.adt7176
Citations
5
Primary Topic
Tryptophan and brain disorders
Type
article
Field-Weighted Citation Impact
2.89
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Proteomic signatures of corona and herpes viral antibodies identify IGDCC4 as a mediator of neurodegeneration

Susan M. Resnick, Yuhan Cui, Timothy J. Hohman, Nicholas James Ashton et al.
5 citations
Science Advances
Tryptophan and brain disorders
2.89
article

Proteomic signatures of corona and herpes viral antibodies identify IGDCC4 as a mediator of neurodegeneration

Susan M. Resnick, Yuhan Cui, Timothy J. Hohman, Nicholas James Ashton, David Alan Bennett, Ana W. Capuano, Brion S. Maher, Kaj Blennow, Logan C. Dumitrescu, Güray Erus, Gabriela Gómez, David Zweibaum, Jingsha Chen, Christos A. Davatzikos, Rebecca F. Gottesman, Przemysław Radosław Kac, Josef Coresh, Luigi Ferrucci, Michael R. Duggan, Thomas K. Karikari, Qu Tian, Julián Candia, Abhay Moghekar, Alexandria Lewis, Keenan A. Walker, Adam P. Spira, Henrik Zetterberg, Junhao Wen, Murat Bilgel, Robert H. Yolken, Shuojia Yang, Shannon M. Drouin, Zhijian Yang
article en
5 citations

Abstract

Mechanisms underlying the dynamic relationships of viral infections and neurodegeneration warrant examination. Using a community-based cohort of older adults, the current study characterized the neurocognitive (cognitive functioning, brain volumes, Alzheimer's disease positron emission tomography, and plasma biomarkers) and plasma proteomic (7268 proteins) profiles of four common coronavirus and six herpesvirus antibody titers. Genetic inference techniques demonstrated the associations between viral antibody titers and neurocognitive outcomes may be attributed to altered expression in a subset of mechanistically relevant proteins in plasma. One of these proteins, IGDCC4 (immunoglobulin superfamily deleted in colorectal cancer subclass member 4), was related to 20-year dementia risk, cognitive functioning, and amyloid-β positivity using data from two independent cohorts, while its plasma and intrathecal abundance were causally implicated in dementia risk and clinically relevant brain atrophy. Our findings illuminate the biological basis by which host immune responses to viruses may affect neurocognitive outcomes in older adults and identify IGDCC4 as an important molecular mediator of neurodegeneration.

Science AdvancesVol. 11(22)
University of Science and Technology of China (CN), Rush University Medical Center (US), National Institutes of Health (US), University of Wisconsin–Madison (US), Johns Hopkins University (US), University of Pittsburgh (US), King's College London (GB), Anhui Medical University (CN), Johns Hopkins Medicine (US), Stavanger University Hospital (NO), Sahlgrenska University Hospital (SE), Stanley Foundation (US), Centre for Mental Health (GB), Sorbonne Université (FR), National Institute of Neurological Disorders and Stroke (US), UK Dementia Research Institute (GB), First Affiliated Hospital of Anhui Medical University (CN), National Institute on Aging (US), Center for Innovation (US), New York Genome Center (US), Artificial Intelligence in Medicine (Canada) (CA), University College London (GB), New York University (US), Columbia University (US), University of Pennsylvania (US), University of Gothenburg (SE), Vanderbilt University Medical Center (US)
Good health and well-being
Openalex Percentile: Top 9%
Tryptophan and brain disorders
2.89
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.